Immunotherapies for Neurologic Diseases
-10%
portes grátis
Immunotherapies for Neurologic Diseases
Dalakas, Marinos C.
Elsevier - Health Sciences Division
02/2026
492
Dura
Inglês
9780323908870
15 a 20 dias
Descrição não disponível.
1. Introduction to Neuroimmunotherapies: An impressive progress towards targeted effective biologics
Section 1. Special Invited Chapters: Evolution of Autoimmune Neurology
2. Autoimmune encephalitis, Autoimmune dementias and Autoimmune psychotic disorders
3. The History of Paraneoplastic Neurologic Disorders of the CNS, PNS, and Autonomic Nervous Systems: Perspective on the Past Towards a Brighter Future
Section 2. Basic principles of immune activation in neurological diseases as related to targeted immunotherapies
4. Role of B cells and pathogenic autoantibodies in autoimmune CNS and PNS Neurologic diseases
5. Role of complement in neurological autoimmunities: why need to target complement activation for effective immunotherapy
6. Paraneoplastic autoimmune neurological disorders and role of immune checkpoint inhibitors
Section 3. Immunotherapeutic agents in Autoimmune Neurological Diseases: Current and evolving biologics
7. The evolution and current status of anti-B cell therapies in autoimmune Neurologic diseases
8. Evolving targeted biologics against T cells, cytokines and intracellular immune targets for multiple sclerosis with implications in other autoimmune neurological diseases
9. FcRn inhibitors: a new era in neurotherapeutics
10. Intravenous Immunoglobulin (IVIg) use in Neurology
11. HSCT for Multiple sclerosis: Improving understanding and addressing misconceptions
12. Autonomic nervous system autoimmunity and proposed immunotherapies
Section 4.? Immunotherapies for specific Neurological Diseases (how do I do it): A step-by step approach based on evidence-based indications with a view to the future
13. Immunotherapies on Autoimmune Encephalitis
14. Immunotherapies in Relapsing-remitting Multiple sclerosis
15. Immunotherapies in progressive Multiple sclerosis
16. Disease Modifying Therapy in Pediatric Multiple Sclerosis
17. Immunotherapies for neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
18. Immunotherapies in Autoimmune Movement Disorders and Cerebellar Ataxia
19. Immunobiology and Immunotherapies in Stiff-person syndrome and GAD antibody-spectrum disorders: Present and future therapeutic prospects
20. Immunotherapies on Guillain-Barre syndrome and other Acute Autoimmune neuropathies
21. Immunotherapies in CIDP and other Chronic Autoimmune Neuropathies
22. Immunotherapy considerations for distal sensory-predominant and small fiber peripheral neuropathies
23. Immunotherapies in Autoimmune neuromuscular Junction disorders: Acute and Chronic management
24. Immunotherapies in Autoimmune Inflammatory Myopathies: Rationale and therapeutic updates
25. The Future Unfolded: CAR T Cells and the Transformation of Treatment Algorithms in Autoimmune Neurology
Section 1. Special Invited Chapters: Evolution of Autoimmune Neurology
2. Autoimmune encephalitis, Autoimmune dementias and Autoimmune psychotic disorders
3. The History of Paraneoplastic Neurologic Disorders of the CNS, PNS, and Autonomic Nervous Systems: Perspective on the Past Towards a Brighter Future
Section 2. Basic principles of immune activation in neurological diseases as related to targeted immunotherapies
4. Role of B cells and pathogenic autoantibodies in autoimmune CNS and PNS Neurologic diseases
5. Role of complement in neurological autoimmunities: why need to target complement activation for effective immunotherapy
6. Paraneoplastic autoimmune neurological disorders and role of immune checkpoint inhibitors
Section 3. Immunotherapeutic agents in Autoimmune Neurological Diseases: Current and evolving biologics
7. The evolution and current status of anti-B cell therapies in autoimmune Neurologic diseases
8. Evolving targeted biologics against T cells, cytokines and intracellular immune targets for multiple sclerosis with implications in other autoimmune neurological diseases
9. FcRn inhibitors: a new era in neurotherapeutics
10. Intravenous Immunoglobulin (IVIg) use in Neurology
11. HSCT for Multiple sclerosis: Improving understanding and addressing misconceptions
12. Autonomic nervous system autoimmunity and proposed immunotherapies
Section 4.? Immunotherapies for specific Neurological Diseases (how do I do it): A step-by step approach based on evidence-based indications with a view to the future
13. Immunotherapies on Autoimmune Encephalitis
14. Immunotherapies in Relapsing-remitting Multiple sclerosis
15. Immunotherapies in progressive Multiple sclerosis
16. Disease Modifying Therapy in Pediatric Multiple Sclerosis
17. Immunotherapies for neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
18. Immunotherapies in Autoimmune Movement Disorders and Cerebellar Ataxia
19. Immunobiology and Immunotherapies in Stiff-person syndrome and GAD antibody-spectrum disorders: Present and future therapeutic prospects
20. Immunotherapies on Guillain-Barre syndrome and other Acute Autoimmune neuropathies
21. Immunotherapies in CIDP and other Chronic Autoimmune Neuropathies
22. Immunotherapy considerations for distal sensory-predominant and small fiber peripheral neuropathies
23. Immunotherapies in Autoimmune neuromuscular Junction disorders: Acute and Chronic management
24. Immunotherapies in Autoimmune Inflammatory Myopathies: Rationale and therapeutic updates
25. The Future Unfolded: CAR T Cells and the Transformation of Treatment Algorithms in Autoimmune Neurology
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Immunotherapy; immunosuppressants; autoimmune disease; autoimmunity; neurological disease; neurology
1. Introduction to Neuroimmunotherapies: An impressive progress towards targeted effective biologics
Section 1. Special Invited Chapters: Evolution of Autoimmune Neurology
2. Autoimmune encephalitis, Autoimmune dementias and Autoimmune psychotic disorders
3. The History of Paraneoplastic Neurologic Disorders of the CNS, PNS, and Autonomic Nervous Systems: Perspective on the Past Towards a Brighter Future
Section 2. Basic principles of immune activation in neurological diseases as related to targeted immunotherapies
4. Role of B cells and pathogenic autoantibodies in autoimmune CNS and PNS Neurologic diseases
5. Role of complement in neurological autoimmunities: why need to target complement activation for effective immunotherapy
6. Paraneoplastic autoimmune neurological disorders and role of immune checkpoint inhibitors
Section 3. Immunotherapeutic agents in Autoimmune Neurological Diseases: Current and evolving biologics
7. The evolution and current status of anti-B cell therapies in autoimmune Neurologic diseases
8. Evolving targeted biologics against T cells, cytokines and intracellular immune targets for multiple sclerosis with implications in other autoimmune neurological diseases
9. FcRn inhibitors: a new era in neurotherapeutics
10. Intravenous Immunoglobulin (IVIg) use in Neurology
11. HSCT for Multiple sclerosis: Improving understanding and addressing misconceptions
12. Autonomic nervous system autoimmunity and proposed immunotherapies
Section 4.? Immunotherapies for specific Neurological Diseases (how do I do it): A step-by step approach based on evidence-based indications with a view to the future
13. Immunotherapies on Autoimmune Encephalitis
14. Immunotherapies in Relapsing-remitting Multiple sclerosis
15. Immunotherapies in progressive Multiple sclerosis
16. Disease Modifying Therapy in Pediatric Multiple Sclerosis
17. Immunotherapies for neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
18. Immunotherapies in Autoimmune Movement Disorders and Cerebellar Ataxia
19. Immunobiology and Immunotherapies in Stiff-person syndrome and GAD antibody-spectrum disorders: Present and future therapeutic prospects
20. Immunotherapies on Guillain-Barre syndrome and other Acute Autoimmune neuropathies
21. Immunotherapies in CIDP and other Chronic Autoimmune Neuropathies
22. Immunotherapy considerations for distal sensory-predominant and small fiber peripheral neuropathies
23. Immunotherapies in Autoimmune neuromuscular Junction disorders: Acute and Chronic management
24. Immunotherapies in Autoimmune Inflammatory Myopathies: Rationale and therapeutic updates
25. The Future Unfolded: CAR T Cells and the Transformation of Treatment Algorithms in Autoimmune Neurology
Section 1. Special Invited Chapters: Evolution of Autoimmune Neurology
2. Autoimmune encephalitis, Autoimmune dementias and Autoimmune psychotic disorders
3. The History of Paraneoplastic Neurologic Disorders of the CNS, PNS, and Autonomic Nervous Systems: Perspective on the Past Towards a Brighter Future
Section 2. Basic principles of immune activation in neurological diseases as related to targeted immunotherapies
4. Role of B cells and pathogenic autoantibodies in autoimmune CNS and PNS Neurologic diseases
5. Role of complement in neurological autoimmunities: why need to target complement activation for effective immunotherapy
6. Paraneoplastic autoimmune neurological disorders and role of immune checkpoint inhibitors
Section 3. Immunotherapeutic agents in Autoimmune Neurological Diseases: Current and evolving biologics
7. The evolution and current status of anti-B cell therapies in autoimmune Neurologic diseases
8. Evolving targeted biologics against T cells, cytokines and intracellular immune targets for multiple sclerosis with implications in other autoimmune neurological diseases
9. FcRn inhibitors: a new era in neurotherapeutics
10. Intravenous Immunoglobulin (IVIg) use in Neurology
11. HSCT for Multiple sclerosis: Improving understanding and addressing misconceptions
12. Autonomic nervous system autoimmunity and proposed immunotherapies
Section 4.? Immunotherapies for specific Neurological Diseases (how do I do it): A step-by step approach based on evidence-based indications with a view to the future
13. Immunotherapies on Autoimmune Encephalitis
14. Immunotherapies in Relapsing-remitting Multiple sclerosis
15. Immunotherapies in progressive Multiple sclerosis
16. Disease Modifying Therapy in Pediatric Multiple Sclerosis
17. Immunotherapies for neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
18. Immunotherapies in Autoimmune Movement Disorders and Cerebellar Ataxia
19. Immunobiology and Immunotherapies in Stiff-person syndrome and GAD antibody-spectrum disorders: Present and future therapeutic prospects
20. Immunotherapies on Guillain-Barre syndrome and other Acute Autoimmune neuropathies
21. Immunotherapies in CIDP and other Chronic Autoimmune Neuropathies
22. Immunotherapy considerations for distal sensory-predominant and small fiber peripheral neuropathies
23. Immunotherapies in Autoimmune neuromuscular Junction disorders: Acute and Chronic management
24. Immunotherapies in Autoimmune Inflammatory Myopathies: Rationale and therapeutic updates
25. The Future Unfolded: CAR T Cells and the Transformation of Treatment Algorithms in Autoimmune Neurology
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
